Moleculin Biotech, Inc. (MBRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 5300 MEMORIAL DRIVE
HOUSTON, TX 77007
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments43,14570,90315,17310,7357,1347,714
Cash and cash equivalents43,14570,90315,17310,7357,1347,714
Receivables 2245110  
Prepaid expense 6005897432,749840588
Other undisclosed current assets1,8299601,281(10)  
Total current assets:45,59672,49717,19813,4847,9748,302
Noncurrent Assets
Operating lease, right-of-use asset403107202287
Property, plant and equipment27533848331646333
Intangible assets, net (including goodwill), including:11,14811,14811,14811,14811,14811,148
Intangible assets, net (excluding goodwill) 11,10011,10011,100   
Other undisclosed intangible assets, net (including goodwill)48484811,14811,14811,148
Total noncurrent assets:11,82611,59311,83311,75111,61111,181
TOTAL ASSETS:57,42284,09029,03125,23519,58519,483
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,8193,6222,9203,5703,5481,712
Accounts payable2,0951,3641,1292,1531,246810
Accrued liabilities2,7242,2581,7911,4172,302902
Deferred compensation liability     150 
Derivative instruments and hedges, liabilities     180503
Total current liabilities:4,8193,6222,9203,5703,8782,215
Noncurrent Liabilities
Long-term debt and lease obligation:  63159276  
Liabilities, other than long-term debt4121,4128,1925,8181,435150
Deferred compensation liability, classified      150
Deferred rent credit     107
Operating lease, liability33563159276
Derivative instruments and hedges, liabilities771,4128,1925,8181,328 
Total noncurrent liabilities:4121,4758,3516,0941,435150
Total liabilities:5,2315,09711,2719,6645,3132,365
Equity
Equity, attributable to parent, including:52,19178,99317,76015,57114,27217,118
Common stock292969462921
Common stock, share subscribed but unissued, subscriptions receivable   (129)   
Additional paid in capital153,985151,73374,67155,05540,56431,577
Accumulated deficit(101,835)(72,810)(56,916)(39,561)(26,356)(14,480)
Other undisclosed equity, attributable to parent1241653135 
Total equity:52,19178,99317,76015,57114,27217,118
TOTAL LIABILITIES AND EQUITY:57,42284,09029,03125,23519,58519,483

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues     9
Sublease income    
Other income      9
Gross profit:     9
Operating expenses(30,640)(22,968)(19,742)(17,524)(15,025)(8,653)
Other undisclosed operating loss     (9)
Operating loss:(30,640)(22,968)(19,742)(17,524)(15,025)(8,653)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
40402815(40) 
Loss from continuing operations before equity method investments, income taxes:(30,600)(22,928)(19,714)(17,509)(15,065)(8,653)
Other undisclosed income from continuing operations before income taxes   2,359   
Loss from continuing operations before income taxes:(30,600)(22,928)(17,355)(17,509)(15,065)(8,653)
Income tax benefit    229  
Loss from continuing operations:(30,600)(22,928)(17,355)(17,280)(15,065)(8,653)
Loss before gain (loss) on sale of properties:(22,928)(17,355)(17,280)(15,065)(8,653)
Net loss:(30,600)(22,928)(17,355)(17,280)(15,065)(8,653)
Other undisclosed net income (loss) attributable to parent1,5757,034 4,0753,189(1,152)
Net loss available to common stockholders, diluted:(29,025)(15,894)(17,355)(13,205)(11,876)(9,805)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(30,600)(22,928)(17,355)(17,280)(15,065)(8,653)
Comprehensive loss:(30,600)(22,928)(17,355)(17,280)(15,065)(8,653)
Other undisclosed comprehensive income, net of tax, attributable to parent1,5467,010344,0713,224 
Comprehensive loss, net of tax, attributable to parent:(29,054)(15,918)(17,321)(13,209)(11,841)(8,653)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: